A Dose-Ranging Study of AAV-hAADC Therapy in Parkinsonian Monkeys
Open Access
- 31 October 2006
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 14 (4), 571-577
- https://doi.org/10.1016/j.ymthe.2006.04.008
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Convection-Enhanced Delivery of Adeno-Associated Virus Type 2 (AAV2) into the Striatum and Transport of AAV2 Within Monkey BrainHuman Gene Therapy, 2006
- Comparison of two methods for the analysis of [18F]6-fluoro-l-m-tyrosine PET dataNeuroImage, 2004
- Parkinson's diseaseThe Lancet, 2004
- The Scientific Basis for the Current Treatment of Parkinson's DiseaseAnnual Review of Medicine, 2004
- Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector.2003
- Overlesioned hemiparkinsonian non human primate model correlation between clinical neurochemical and histochemical changesFrontiers in Bioscience-Landmark, 2003
- Parkinson's diseaseNeurologic Clinics, 2001
- Orthostatic Hypotension in Patients with Parkinson??s DiseaseDrugs & Aging, 2001
- Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkeyJournal of Neuroscience Methods, 2000
- Hyperactivity of Remaining Dopaminergic Neurones after Partial Destruction of the Nigro-striatal Dopaminergic System in the RatNature New Biology, 1973